tretinoin

Tretinoin, the first successful differentiating agent, approed by FDA for use in acute promyelocytic leukemia.

FDA批准首个有效的促分化药物-维A酸治疗急性早幼粒细胞白血病.

Clinical nursing care of 18 patients with acute promyelocytic leukemia treated with Tretinoin combined with Arsenious acid and a small dose of Daunorubicin

维甲酸联合亚砷酸、小剂量柔红霉素治疗急性早幼粒细胞白血病18例临床护理

Aim In vitro dissolution test and pharmacokinetics in beagle dogs were conducted to assess the formulation of tretinoin in self-emulsifying systems.

目的评价维甲酸（RA）自乳化释药系统的体外溶出及在比格犬体内的药动学。

Also combination drug has a lower concentration of tretinoin than 0.1 % tretinoin microsphere gel, he noted.

而且,这种复方药比0.1%维甲酸微凝胶浓度低, 他指出.

Conclusion Compound tretinoin ointment is stable in quality and safe in use, with a reliable effect on dermatosis, especially, inflammatory keratinization. It has a broad prospects in clinical use.

结论复方维A酸软膏是治疗皮肤病（炎症角质化）有效药物，值得推广、应用于临床。

Therapeutic effect of tretinoin compound ointment in arsenical keratosis

复方维甲酸软膏封包治疗砷剂角化病近期疗效观察

Tretinoin treatment before carbon-dioxide laser resurfacing: A clinical and biochemical analysis

二氧化碳激光表面治疗前采用维甲酸治疗：临床和生物化学分析